Amgen stock slides 1.64 percent to $378.89 as price tests crucial $378.22 support

Amgen stock slides 1.64 percent to $378.89 as price tests crucial $378.22 support
Amgen stock slides 1.6% today

Amgen is set to report its second-quarter 2026 financial results tomorrow, the company said. At the same time, Amgen stock is down 1.6% on the day at $378.89.

AMGN price prediction
24H 0.03%
$443.97
48H -0.22%
$442.88
7D -0.86%
$440.01
1M 6.65%
$473.34
3M 17.98%
$523.66
6M 27.15%
$564.35
12M 46.6%
$650.69
Current price: $443.84 -14.0900 3.08%
Closed 11/18
Daily range 441.62 Arrow from to Icon 455.05
Weekly range 441.62 Arrow from to Icon 473.18
Loading...

Highlights

  • Amgen will release second-quarter 2026 financial results tomorrow, offering a timely update on operating performance.
  • Amgen stock fell 1.6% to $378.89 ahead of earnings, with no new company developments disclosed.
  • Shares are testing key support at $378.22 with broadly bullish technicals; expected trading range is $370.04 to $387.73.

Amgen, through its official account, said it will publish its financial results for the second quarter of 2026 on the following day. The announcement points to a forthcoming update on recent performance, a regular event for the drug manufacturer. The post itself serves as a standard notice to investors and the public.

Technical support draws focus as market moves without new news

The post gave traders nothing new to price in, and the session moved on its own logic, as the timing of publication cannot be linked to the market move. Right now, shares of Amgen are being shaped by technical dynamics: the price is sitting right at support from the weekly low at $378.22, while continuing to trade above the MA-20, MA-50, and MA-200, which maintains a bullish daily structure. However, RSI at 64.6 signals that the recent advance is beginning to get stretched and may face some near-term resistance.

Bullish outlook intact as key support level holds

To determine if traders are reacting to new developments, the most important level to watch is the weekly low at $378.22. The price is currently testing this support but has not moved below it, highlighting a key battleground for buyers and sellers. Over the coming trading week, the probability of an upside move is very high at more than 80%, while the chance of a downside break remains very low at less than 20%, with an expected trading range between $370.04 and $387.73. Even though recent price action has remained contained and within a narrow range, a close above $398 would confirm strong buyer interest, while a drop below $378.22 would indicate the move is being faded. On the weekly chart, the longer-term picture remains firmly constructive.

Previously it was reported that Amgen’s technical outlook remained bullish, supported by ongoing upward momentum and stable trend indicators. The current setup reinforces this constructive backdrop, with the weekly low at $378.22 emerging as the pivotal level to watch for confirmation of continued support or the risk of a downside break.

This material may contain third-party opinions, none of the data and information on this webpage constitutes investment advice according to our Disclaimer. While we adhere to strict Editorial Integrity, this post may contain references to products from our partners.